CORTCorcept TherapeuticsHealth Care
$121.19EarningsNov 3, 2026
1D—1W—1M—3M—1Y—
Market cap$14.3BCompany infoRevenue$830.8M52-wk range$32 – $124IndustryBiotechnologyWebsitecorcept.comRelated—
Yahoo
EDGAR
CNN
FinvizMarket Beat
Perform
n/a
1 Year
n/a1 Month
n/a1 Week
n/a1 Day
Rank Durability
Persist
n/a
1 Year
n/a6 Month
n/a3 Month
n/aTrend Hold
Business Beat
Profit
n/a
Composite
n/aRevenue
n/aMargin
n/aCash Flow
Money Flow
Pressure
n/a
60 Day
n/a30 Day
n/a5 Day
n/a2 Day
▲ +44.4% · 1YSPY
Weekly rank vs S&P 500 · 52wk
Not enough history to plot
ValuationHow the price is priced — vs cohort and vs its own past
MetricValueUnivSect5-yr range
P / E288.5×21
22
207
P / S17.3×34
5
20
P / FCF134.2×31
14
96
EV / EBITDA488.0×11
16
347
P / E (fwd)———
ProfitabilityMargins and returns on capital
MetricValueUnivSect5-yr range
Gross margin98.3%99100
98%
99%
Operating margin0.8%814
-1%
35%
Net margin6.6%3441
6%
31%
ROE8.4%3041
7%
26%
ROIC0.9%1017
-1%
30%
Financial healthLeverage and liquidity
MetricValueUnivSect5-yr range
Debt / equity0.019183
0.0
0.0
Net debt / EBITDA-10.4×9797
Current ratio2.868273
Interest coverage999.0×9695
Per shareTTM, with year-over-year change
Revenue / share$7.02▲ +16%
EPS (diluted)$0.42▼ −63%
FCF / share$0.90▼ −41%
Est. EPS growth (fwd)—